
|Articles|January 27, 2020
SU2C Initiative to Increase Diversity in Cancer Clinical Trials
Advertisement
Stand Up To Cancer (SU2C) announced an initiative to increase minority representation in cancer clinical trials. All future SU2C-supported research grant proposals will now be required to include and address crucial issues related to recruitment and retention of patients from ethnic groups to improve diverse participation in cancer clinical trials.
For more information on this initiative, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Honing the Power of AI for Next Generation Trial Oversight and Execution
2
The Value of Pragmatic Randomized Clinical Trials: Strategic Approaches for Real-World Impact
3
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
4
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
5